EXACT Financial Statements From 2010 to 2024

EXAS Stock  USD 66.88  1.64  2.51%   
EXACT Sciences financial statements provide useful quarterly and yearly information to potential EXACT Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on EXACT Sciences financial statements helps investors assess EXACT Sciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting EXACT Sciences' valuation are summarized below:
Gross Profit
1.5 B
Profit Margin
(0.08)
Market Capitalization
12.1 B
Enterprise Value Revenue
5.4508
Revenue
2.5 B
There are over one hundred nineteen available fundamental measures for EXACT Sciences, which can be analyzed over time and compared to other ratios. All traders should verify EXACT Sciences' latest fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.
Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT main balance sheet or income statement drivers, such as Interest Expense of 25.6 M, Other Operating Expenses of 2.8 B or Research Development of 447.2 M, as well as many exotic indicators such as Short Term Coverage Ratios of 2.07, Price To Sales Ratio of 5.06 or Dividend Yield of 0.0127. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.
  
This module can also supplement EXACT Sciences' financial leverage analysis and stock options assessment as well as various EXACT Sciences Technical models . Check out the analysis of EXACT Sciences Correlation against competitors.
For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

EXACT Sciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.8 B6.5 B2.5 B
Slightly volatile
Total Stockholder Equity3.3 B3.1 B1.4 B
Slightly volatile
Cash635.6 M605.4 M261.6 M
Slightly volatile
Cash And Short Term Investments816.5 M777.6 M547.6 M
Slightly volatile
Common Stock Shares Outstanding189.2 M180.1 M112.8 M
Slightly volatile
Liabilities And Stockholders Equity6.8 B6.5 B2.5 B
Slightly volatile
Other Stockholder Equity6.9 B6.6 B2.7 B
Slightly volatile
Total Liabilities3.5 B3.3 B1.2 B
Slightly volatile
Total Current Assets1.3 B1.2 B708.4 M
Slightly volatile
Other Current Liabilities20.2 M14.8 M29.3 M
Slightly volatile
Total Current Liabilities540.4 M514.7 M207 M
Slightly volatile
Property Plant And Equipment Net884.2 M842.1 M328.4 M
Slightly volatile
Accounts Payable82.8 M78.8 M28.2 M
Slightly volatile
Non Current Assets Total5.5 B5.3 B1.8 B
Slightly volatile
Common Stock Total Equity2.1 MM1.2 M
Slightly volatile
Other Current Assets89.9 M85.6 M30 M
Slightly volatile
Property Plant And Equipment Gross1.3 B1.3 B385.4 M
Slightly volatile
Common Stock1.9 M1.8 M1.2 M
Slightly volatile
Property Plant Equipment826.8 M787.5 M293 M
Slightly volatile
Other Liabilities416.7 M396.8 M114.2 M
Slightly volatile
Short Term Investments222.6 M172.3 M290.5 M
Slightly volatile
Non Current Liabilities TotalB2.8 B972.2 M
Slightly volatile
Current Deferred Revenue358.8 M341.7 M117.9 M
Slightly volatile
Short and Long Term Debt Total2.7 B2.6 B877.7 M
Slightly volatile
Long Term Debt2.4 B2.3 B799.3 M
Slightly volatile
Long Term Debt Total2.6 B2.5 B883.1 M
Slightly volatile
Capital Surpluse7.6 B7.3 B2.9 B
Slightly volatile
Non Current Liabilities Other352.8 M336 M106.9 M
Slightly volatile
Short Term Debt83.3 M79.4 M32.7 M
Slightly volatile
Net Receivables113 M203.6 M76.4 M
Slightly volatile
Short and Long Term Debt42.4 M57.5 M30.7 M
Slightly volatile
Net Invested Capital4.1 B5.5 B2.2 B
Slightly volatile
Long Term Investments2.4 M2.7 M2.9 M
Slightly volatile
Net Working Capital881.9 M679.7 M628.5 M
Slightly volatile
Capital Stock1.8 M1.8 M1.4 M
Slightly volatile
Capital Lease Obligations189.7 M190.4 M146.1 M
Slightly volatile

EXACT Sciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses2.8 B2.7 BB
Slightly volatile
Research Development447.2 M425.9 M176.5 M
Slightly volatile
Total Operating Expenses2.2 B2.1 B832.3 M
Slightly volatile
Depreciation And Amortization216.9 M206.6 M52.7 M
Slightly volatile
Selling General Administrative1.5 B1.4 B384.9 M
Slightly volatile
Total Revenue2.6 B2.5 B814.5 M
Slightly volatile
Selling And Marketing Expenses217.2 M203.9 M250.9 M
Slightly volatile
Interest Income29.5 M28.1 M12.3 M
Slightly volatile
Reconciled Depreciation131.5 M206.6 M71.8 M
Slightly volatile
Non Recurring13.7 M14.4 M158 M
Slightly volatile

EXACT Sciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow129.5 M242.8 M192.9 M
Slightly volatile
Other Cashflows From Financing Activities427.7 M407.4 M312.5 M
Slightly volatile
Depreciation216.9 M206.6 M72 M
Slightly volatile
Capital Expenditures130.4 M124.2 M74.8 M
Slightly volatile
Total Cash From Financing Activities200.5 M159.8 M300.7 M
Pretty Stable
End Period Cash Flow640.2 M609.7 M261.9 M
Slightly volatile
Stock Based Compensation242.9 M231.3 M90.9 M
Slightly volatile
Change To Netincome131.1 M208.5 M118.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.065.3313341
Slightly volatile
Dividend Yield0.01270.01140.0112
Pretty Stable
Operating Cycle199101298
Slightly volatile
Price Book Value Ratio4.474.23715.5678
Very volatile
Inventory Turnover3.135.1323.1042
Slightly volatile
Ebt Per Ebit0.890.93831.0639
Very volatile
Company Equity Multiplier1.162.05751.443
Slightly volatile
Long Term Debt To Capitalization0.460.44040.2073
Slightly volatile
Cash Per Share4.614.31685.1005
Very volatile
Total Debt To Capitalization0.470.44820.2121
Slightly volatile
Debt Equity Ratio0.850.81220.3642
Slightly volatile
Quick Ratio1.811.90657.7137
Slightly volatile
Net Income Per E B T0.631.01190.9012
Slightly volatile
Cash Ratio1.121.17622.2158
Slightly volatile
Days Of Inventory Outstanding12871.1226177
Slightly volatile
Days Of Sales Outstanding28.2529.7317119
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.190.20451.3778
Very volatile
Price To Book Ratio4.474.23715.5678
Very volatile
Current Ratio2.22.32058.0602
Slightly volatile
Fixed Asset Turnover1.582.96861.7118
Slightly volatile
Debt Ratio0.410.39480.1832
Slightly volatile
Price Sales Ratio5.065.3313341
Slightly volatile
Receivables Turnover7.0412.27646.6858
Slightly volatile
Asset Turnover0.410.38630.2118
Slightly volatile
Price Fair Value4.474.23715.5678
Very volatile

EXACT Fundamental Market Drivers

Cash And Short Term Investments777.6 M

EXACT Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About EXACT Sciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include EXACT Sciences income statement, its balance sheet, and the statement of cash flows. EXACT Sciences investors use historical funamental indicators, such as EXACT Sciences's revenue or net income, to determine how well the company is positioned to perform in the future. Although EXACT Sciences investors may use each financial statement separately, they are all related. The changes in EXACT Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on EXACT Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on EXACT Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in EXACT Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue341.7 M358.8 M
Total Revenue2.5 B2.6 B
Cost Of Revenue654.2 M686.9 M
Ebit Per Revenue(0.09)(0.09)

EXACT Sciences Investors Sentiment

The influence of EXACT Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in EXACT. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to EXACT Sciences' public news can be used to forecast risks associated with an investment in EXACT. The trend in average sentiment can be used to explain how an investor holding EXACT can time the market purely based on public headlines and social activities around EXACT Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
EXACT Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for EXACT Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average EXACT Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on EXACT Sciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EXACT Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EXACT Sciences' short interest history, or implied volatility extrapolated from EXACT Sciences options trading.

Pair Trading with EXACT Sciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EXACT Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXACT Sciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with EXACT Stock

  0.63MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against EXACT Stock

  0.86MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.81MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.79DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.75EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.7MDWD Mediwound Financial Report 4th of June 2024 PairCorr
The ability to find closely correlated positions to EXACT Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EXACT Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EXACT Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EXACT Sciences to buy it.
The correlation of EXACT Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EXACT Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EXACT Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EXACT Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether EXACT Sciences is a strong investment it is important to analyze EXACT Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EXACT Sciences' future performance. For an informed investment choice regarding EXACT Stock, refer to the following important reports:
Check out the analysis of EXACT Sciences Correlation against competitors.
For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.
Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for EXACT Stock analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.13)
Revenue Per Share
13.876
Quarterly Revenue Growth
0.17
Return On Assets
(0.03)
Return On Equity
(0.07)
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.